This is a required course for all Biological Sciences majors to provide students with a deeper understanding of current topics, research and research methods, literature, and controversy in biological sciences. Moreover, students will have the chance to demonstrate their cumulative knowledge of the biology major through presentations, discussions, and written reports. This seminar will be addressing one or more topics including: Social Medicine, Development and Differentiation, Community Health, Neuropathological Mechanisms, Immunology, Pharmaceutical Chemistry, Human Genetics, Evolutionary Medicine. Students are guided to explore the current concerns and interests in the above fields through an in-depth analysis of the related primary biology literature. Thus, they are able to apply and extend the knowledge and skills that they have acquired during their undergraduate Biology training. Pre-requisite: Senior Biological Sciences Status
Bachelor's Thesis II module is the second half of a year-long capstone project, concluding the students’ four-year learning experience in the Biological Sciences program. It is designed to foster research, autonomy, and synthesis of concepts and skills acquired in all other modules. The first half of the capstone project (SNCB 493) is devoted to research/analysis and design, while the second semester counterpart (SNCB 494) places emphasis on implementation, experimental validation, thesis writing, and final project presentation. Pre-requisite: SNCB 493: Bachelor's Thesis I
Chemistry 216: Organic Chemistry II (Spring I 2025, Spring II 2026)
Chemistry 215: Organic Chemistry I (Fall 2025)
Chemistry 117: General Chemistry for Biological Sciences (Spring I 2025, Fall 2025, Spring I 2026)
I currently supervise undergraduate research projects in medicinal chemistry and drug development.
Adria Lockhart (BSc Student): "Synthesis and Biological Evaluation of PBK-Targeting Sulfasalazine Conjugates for Cancer Treatment" (Expected 2026)
Vasiliki-Maria Tzouma (BSc Student): "In Silico Design, Synthesis, and Biological Evaluation of Novel Ilaprazole-Based PBK/TOPK Inhibitors for Cancer Therapy" (Expected 2026)
Doris Leco (BSc Student): "In Silico Evaluation, Synthetic Modification, and Antimicrobial Assessment of Lynamicin Analogues" (Expected 2026)
Theodora Partsou (BSc Student): "In Silico design and proposed Synthesis of Novel Atorvastatin-Derived PBK/TOPK Inhibitors" (Expected 2026)